Possible indications for vitamin D3 analogues in conditions other than psoriasis vulgaris

Journal of Dermatological Treatment

Volumn 7, Issue 3, 1996, Pages 195-198

  Van de Kerkhof, P C M ^a   Wittenhorst, M ^a   Gerritsen, M J P ^a   De Jong, E M G J ^a   Lucker, G P H ^a   Steylen, P M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Vitamin D3 analogues

Indexed keywords

CALCIPOTRIOL; COLECALCIFEROL DERIVATIVE;

ARTICLE; CONGENITAL ICHTHYOSIFORM ERYTHRODERMA; DYSKERATOSIS; HUMAN; PITYRIASIS RUBRA PILARIS; PRIORITY JOURNAL; PSORIASIS VULGARIS; PUSTULAR PSORIASIS; SKIN DISEASE;

EID: 0029861225     PISSN: 09546634     EISSN: None     Source Type: Journal    
DOI: 10.3109/09546639609086888     Document Type: Article

References (41)

1. 3 (calcitriol) ointment in psoriasis. J Dermatol Treat (1992) 3: 177-80.
2. 3 for the treatment of psoriasis. Review of the literature. Eur J Dermatol (1993) 3:255-61.
3. Kragballe K, Iversen L, Calcipotriol: a new topical antipsoriatic. Dermatol Ther (1993) 11: 137-44.
4. Ramsay CA, Berth-Jones J, Brundin G et al., Long-term use of topical calcipotriol in chronic plaque psoriasis. Dermatology (1994) 189: 260-1.
5. Poyner T, Hughes IW, Dass BK et al. Long-term treatment of chronic plaque psoriasis with calcipotriol, J Dermatol Treat (1993) 4: 173-7.
6. 3. J Bone Miner Res (1991) 6: 1021-7.
7. 3 signalling. Nature (1992) 355:446-9.
8. Carlberg C, Bendik I, Wyss A et al. Two nuclear signalling pathways for vitamin D. Nature (1993) 361: 657-60.
9. 3 increases intracellular calcium in human keratinocytes. Br J Dermatol (1991) 124: 230-5.
10. Pillai S, Bikle DD, Elias PM, 1,25-Dihydroxyvitamin D production and receptor binding in human keratinocytes varies with differentiation. J Biol Chem (1988) 263: 5390-5.
11. 3 increases calcium and phosphatidylinositol metabolism in differentiating cultured human keratinocytes. J Nutr Biochem (1990) 1: 81-7.
12. 3: role of protein kinase C translocation. Biochem Biophys Res Commun (1989) 163: 1517-22.
13. Binderup L, Bramm E, Effects of a novel vitamin D analogue MC903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo. Biochem Pharmacol (1988) 37: 889-95.
14. 3 analogue, stimulates terminal differentiation and inhibits proliferation of cultured human keratinocytes. Arch Dermatol Res (1990) 282: 164-7.
15. 3. Endocrinology (1983) 113: 1950-7.
16. 3 on the morphological and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions. J Invest Dermatol (1986) 86: 709-14.
17. Holick MF, Vitamin D: biosynthesis, metabolism and mode of action. In: De Groot LJ (ed), Endocrinology. Grune and Stratton: New York, 1989, pp 902-26.
18. 3 stimulates specifically the last steps of epidermal differentiation of cultured human keratinocytes. Differentiation (1991) 47: 173-88.
19. 3 on the transglutaminase activity of transformed mouse epidermal cells in culture. J Dermatol (1989) 16:7-11.
20. 3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia. Endocrinology (1991) 129: 832-7.
21. 3: a novel immunoregulatory hormone. Science (1984) 224: 1438-40.
22. 3. J Cell Biochem (1992) 49: 26-31.
23. 3 to elicitation site. Arch Dermatol Res (1989) 281: 355-61.
24. 3 and MC903 on the production of IL-6, γ-IFN and T lymphocyte proliferation in peripheral blood mononuclear cells. J Bone Miner Res (1991) 6: S292 (abstract).
25. 3 and retinoic acid in the regulation of CD14 and CD23 expression during monocytic differentiation of U-937 cells. J Immunol (1993) 150: 3487- 95.
26. 3 down-regulation of HLA-DR on human peripheral blood monocytes. Immunology (1992) 75: 349-54.
27. 4 and 5-hydroxyeicosatetraenoic acid by rat peritoneal neutrophils. Prostaglandins Leukot Essent Fatty Acids (1988) 32: 9-14.
28. Zhou JY, Norman AW, Lübbert M et al., Novel vitamin D analogues that modulate leukemic cell growth and differentiation with little effect on either intestinal calcium absorption or bone mobilization. Blood (1989) 74: 82-93.
29. 3 analogue MC903: modulations and interrelations. Br J Dermatol (1991) 124: 221 -9.
30. 3) on cutaneous inflammation, epidermal proliferation and keratinization in psoriasis: a placebo-controlled, double-blind study. Br J Dermatol (1994) 131: 57-63.
31. Gerritsen MJP, Rulo HFC, van Vlijmen-Willems et al., Topical treatment of psoriatic plaques with 1,25-dihydroxycholecalciferol: a cell biological study. Br J Dermatol (1993) 128: 666-73.
32. Berth-Jones J, Bourke J, Baily K et al., Generalised pustular psoriasis: response to topical calcipotriol. BMJ (1992) 305:868-9.
33. Kuypers A, van Dooren-Greebe RJ, van de Kerkhof PCM, Acrodermatitis continua Hallopeau: response to combined treatment with acitretin and calcipotriol ointment. Dermatology (in press).
34. Kragballe K, Steylen PM. Ibsen HH et al., Efficacy, tolerability and safety of calcipotriol ointment in disorders of keratinization. Arch Dermatol (1995) 131: 556-60.
35. Lucker G, Steylen PM, van de Kerkhof PCM, Calcipotriol in the treatment of congenital ichthyosis. Br J Dermatol (1994) 131: 546-50.
36. Lucker GPH, van de Kerkhof PCM, Cruysberg JRM et al., Topical treatment of Sjögren-Larsson syndrome with calcipotriol, a clinical study. Dermatology (1995) 190: 242-4.
37. Van de Kerkhof PCM, Steylen PM. Topical treatment of pityriasis rubra pilaris with calcipotriol. Br J Dermatol (1994) 130:675-8.
38. Lucker GPH, van de Kerkhof PCM, Steylen PM. Calcipotriol in the treatment of palmoplantor keratoderma of the epidermolytic type (Vörner). Br J Dermatol (1994) 130:543-5.
39. Gatti S, Carozzo AM, Orlandi A et al., Treatment of inflammatory linear verrucous epidermal naevus with calcipotriol. Br J Dermatol (1995) 132: 837-9.
40. de Jong EMGJ, Rulo HFC, van de Kerkhof PCM, Inflammatory verrucous epidermal naevus (ILVEN) versus linear psoriasis; a clinical histological and immunohistochemical study. Acta Derm Venereol (Stockh) (1991) 71: 343-6.
41. R). Br J Dermatol (1995) 132: 832-3.